Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viruses as vectors.

C J Bostock1

  • 1A.F.R.C. Institute for Animal Health, Pirbright Laboratory, Nr Woking, Surrey, Great Britain.

Veterinary Microbiology
|June 1, 1990
PubMed
Summary

New recombinant virus vaccines offer enhanced safety and efficacy. Researchers are engineering viruses like vaccinia virus to express foreign antigens, with poxviruses showing promise for veterinary applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine.

Epidemiology and infection·2002
Same author

The potential size and duration of an epidemic of bovine spongiform encephalopathy in British sheep.

Science (New York, N.Y.)·2001
Same author

Scrapie strains maintain biological phenotypes on propagation in a cell line in culture.

The EMBO journal·2001
Same author

Scrapie infections initiated at varying doses: an analysis of 117 titration experiments.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2001
Same author

Transmission of BSE by blood transfusion in sheep.

Lancet (London, England)·2000
Same author

Characterization and polyanion-binding properties of purified recombinant prion protein.

The Biochemical journal·1999

Area of Science:

  • Molecular Biology
  • Vaccinology
  • Virology
  • Immunology

Background:

  • Traditional viral vaccines rely on live attenuated or killed virus preparations.
  • Molecular biology enables novel vaccine strategies with improved safety and efficacy.
  • Genetically engineered viruses can serve as vectors for expressing foreign antigens.

Purpose of the Study:

  • To explore the potential of recombinant virus vectors for vaccine development.
  • To evaluate vaccinia virus as a primary candidate for recombinant virus vaccines.
  • To investigate the advantages of poxviruses with restricted host ranges for veterinary vaccines.

Main Methods:

  • Genetic manipulation of viruses to carry and express foreign genes encoding protective antigens.
  • Engineering of adeno-, polio-, herpes-, and vaccinia viruses as expression vectors.
  • Development and assessment of recombinant avipoxviruses and capripoxviruses.

Main Results:

  • Vaccinia virus is a primary candidate for recombinant virus vector vaccines due to its broad host range.
  • Recombinant viruses facilitate the analysis of foreign antigen expression and immune system dissection.
  • Poxviruses with restricted host ranges, such as avipoxviruses and capripoxviruses, offer advantages for veterinary vaccines.

Conclusions:

  • Recombinant virus technology presents a promising avenue for developing safer and more effective vaccines.
  • Vaccinia virus serves as a valuable tool for antigen expression and immune studies.
  • Avipoxviruses and capripoxviruses are being developed as prototype vaccines for poultry and ruminants, respectively.

Related Experiment Videos